-
Specialties
- Adult Behavioral Health
- Addiction Psychiatry
- Mood Disorders
- Neuromodulation
- Psychosis
Board Certification
American Board of Psychiatry & Neurology (Psychiatry)Educational Commission for Foreign Medical GraduatesNational Board of Medical Examiners -
Board Certification and Academic Information
Academic Departments Psychiatry -Primary Academic Divisions Adult Psychiatry
Board Certification American Board of Psychiatry & Neurology (Psychiatry)Educational Commission for Foreign Medical GraduatesNational Board of Medical ExaminersEducation history
Certification University of Utah Clinical Teaching Certificate - University of Utah Certification University of Utah David Eccles of School of Business Certification Post Graduate Training Psychiatry - University of Utah Resident Psychiatry - University of Utah Intern Residency Psychiatry - Bakırköy Psychiatric Hospital Resident Medicine - University of Istanbul M.D. Selected Publications
Journal Article
- Tadler SC, Jones KG, Lybbert C, Huang JC, Jawish R, Solzbacher D, Kendrick EJ, Pierson MD, Weischedel K, Rana N, Jacobs R, Vonesh LC, Feldman DA, Larson C, Hoffman N, Jessop JE, Larson AL, Taylor NE, Odell DH, Kuck K, Mickey BJ (2023). Propofol for treatment resistant depression: A randomized controlled trial.
- Oka F, Weischedel K, Bakian A, Mickey BJ (2022). Treatment-Resistant Mood Disorders in LGBTQ People: A Retrospective Study of Clinical Features and Response to Electroconvulsive Therapy. J Clin Psychiatry, 83(4).
- Palmese LB, Ratliff JC, Reutenauer EL, Tonizzo KM, Grilo CM, Tek C (2013). Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorder. Compr Psychiatry, 54(3), 276-81.
- Ratliff JC, Palmese LB, Tonizzo KM, Chwastiak L, Tek C (2012). Contingency management for the treatment of antipsychotic-induced weight gain: a randomized controlled pilot study. Obes Facts, 5(6), 919-27.
Book Chapter
- Hershenberg R, Rapaport M, Weischedel K (2022). Identification and management of anxious depression in patients with treatment-resistant depression. In Hershenberg R|Rapaport M|Weischedel K (Ed.), Managing Treatment-Resistant Depression: Road to Novel Therapeutics (pp. 415-440).
Case Report
- Durns T, Rich B, Benson C, Mickey B, Weischedel K (2020). A Case of Biopharmaceutical-induced Catatonia and The Implication of a Novel Mechanism . J ECT, 36(2), e29-e30.